Concepedia

Rachel K. Miller

RK

32

Publications

3.1K

Citations

23

H-Index

1993

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Emory University

University of Oxford

Baylor College of Medicine

Rachel K. Miller is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and morphogenesis.

ORCID

Top concepts

Publications per year

1993–2024

32

Publications

32

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Lung epithelial branching program antagonizes alveolar differentiation

Daniel R. Chang, Denise Martinez Alanis, Rachel K. Miller et al. · Proceedings of the National Academy of Sciences · 2013 · 189 citations · Full text

, , +19

Rows per page

1–5 of 32